Introduction {#sec1}
============

Thiosugars, 4-thiofuranosides and 5-thiopyranosides, are sugars that have their endocyclic oxygen substituted for a sulfur atom. These compounds have been found in nature, such as salacinol ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **A**), an antidiabetes compound isolated from *Salacia reticulata* that acts as a glycosidase inhibitor. Most thiosugars reported to date are man-made, and they have been designed and generated to function as mimics of their parent *O*-glycosides. As they are generally more stable toward both enzymatic^[@ref1]^ and nonenzymatic hydrolysis,^[@ref2]^ they may function as inhibitors for carbohydrate-processing enzymes. Indeed, the thiosugars and thio-oligosaccharides reported to date are moderately active glycosidase inhibitors, with activity in the micro to millimolar range.^[@ref3]^ Prominent 4-thiofuranosides that have been studied for their therapeutic potential owing to their increased chemical stability,^[@ref2]^ include the 4′-thio analogues of DNA and RNA nucleotides ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **B**), and they have shown antiviral,^[@ref4],[@ref5]^ antibiotic,^[@ref6]^ and anticancer^[@ref6],[@ref7]^ properties. The 4′-thio analogue of cADPR ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, **C**), which is resistant to enzymatic degradation, is a mimic of the naturally occurring cADPR, an important mediator of intracellular Ca^2+^ signaling.^[@ref8]^ Recently, the 4-thioribose nicotinamide adenoside diphosphate (thio-NAD^+^, **D**) was introduced as a stabilized NAD^+^ analogue, allowing for crystallographic studies of enzymes using this oft-used cofactor.^[@ref9]^

![Examples of biologically relevant 4-thiofuranosides.](jo-2018-025365_0001){#fig1}

To probe the stability and reactivity of thiosugars, these substrates have been subjected to various studies. In 1963, Whistler and Van Es described that methyl 5-thioxylopyranoside is hydrolyzed significantly faster than its *O*-counterpart^[@ref10]^ and Bennet and co-workers performed an extensive suite of KIE experiments to establish that *xylo*- and *gluco*-thiacarbenium ions are more stable than the corresponding oxocarbenium ions in aqueous hydrolysis reactions.^[@ref11],[@ref12]^ Experimental and theoretical evidence shows that sulfur atoms stabilize an adjacent carbocation better than an oxygen atom.^[@ref13]^ However, Jagannadham et al. determined that the thermodynamically less stable, α-oxygen-stabilized, carbocation can form more rapidly than their thermodynamically more stable α-sulfur-stabilized counterparts, as the intrinsic kinetic barrier to the formation of the oxocarbenium ion is smaller compared to the formation of the thiacarbenium ion.^[@ref14]^ The increased rate of hydrolysis of the thiopyranosides might be due to an additional ring strain of substituting an oxygen atom for a significantly bigger sulfur atom. In contrast, a study regarding the acid-catalyzed hydrolysis of 4-thio nucleosides has revealed a significant decrease in reactivity compared to the natural 4-oxo nucleosides,^[@ref2]^ which is more in line with the reactivity of the acyclic benzylic substrates described by Jagannadham et al.^[@ref14]^ To understand the stability and reactivity of furanosyl thiacarbenium ions, in support of the use of 4-thiofuranosides as stabilized furanose analogues, we here describe the synthesis of the full suite of diasteroisomeric thiofuranosides (thio-*ribose*, thio-*arabinose*, thio-*xylose*, and thio-*lyxose*, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and a study to map structure--reactivity-stereoselectivity relationships of these thiafuranosyl acetyl donors in Lewis-acid-mediated S~N~1-type substitution reactions. The putative ribosyl, arabinosyl, xylosyl, and lyxosyl thiacarbenium ion intermediates were investigated computationally following a computational method, which we recently developed to establish the stability and reactivity of fully decorated furanosyl oxocarbenium ions.^[@ref15],[@ref16]^ In this method, which we built on the seminal work of Rhoad and co-workers,^[@ref17]^ the relative energy of furanosyl oxocarbenium ions is determined as a function of their overall shape. It was found that the low-energy oxocarbenium ion conformers could accurately account for the stereoselectivity of addition reactions taking place on these intermediates, thereby lending strong support for their intermediacy in the studied reactions. To investigate the reactivity/stability of the related thiacarbenium ions and establish whether the stabilizing/destabilizing substituent effects that dictate the stability and reactivity of furanosyl oxocarbenium ions are operational in thiacarbenium ions, we here extend the method to five-membered ring thiacarbenium ions. It is found that these stereoelectronic effects indeed translate well to the thiacarbenium ions and the stereoselectivity of reactions of thiafuranosyl donors, in which these cations feature as product-forming intermediates can be well accounted for by the shape of the intermediate ions.

![Four Studied 4-Thiofuranosyl Donors](jo-2018-025365_0003){#sch1}

Results and Discussion {#sec2}
======================

The four required 4-thiofuranosyl donors ribose **1**, lyxose **2**, arabinose **3**, and xylose **4** were synthesized following the method reported by Minakawa et al. as depicted in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}.^[@ref18]^ The synthesis of the 4-thio ribosyl donor **1** started from [d]{.smallcaps}-ribose to afford, after standard protecting group manipulations, 2,3,5-tri-*O*-benzyl ribose **7** in 88% yield over three steps. Reduction of the lactol with sodium borohydride in methanol yielded the corresponding ribitol, of which both hydroxyl functionalities were mesylated to provide dimesylate **9**. To generate the thio-ribofuranosyl donor **1**, a double inversion of the C-4-mesylate was required. To this end, both mesylates in **9** were substituted by bromines in a Finkelstein-type reaction. Next, a second substitution and concomitant ring closure were effected by an S~N~2 substitution using sodium sulfide in DMF at 100 °C to give thioether **11** in 63% over three steps. These last two reactions required specific attention, as epimerization can occur on both the C3 and C4 positions, leading to the formation of a mixture of stereoisomers. (See the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.8b02536/suppl_file/jo8b02536_si_001.pdf) for more information.) To deliver the required acetyl donor **1**, thioether **11** was oxidized with *m*-CPBA, to give the corresponding sulfoxide, which was transformed through a Pummerer rearrangement in donor **1** in 81% yield over two steps. Dimesylate **9** was also used for the construction of the 4-thio lyxofuranosyl donor **2**. To this end, **9** was exposed to the sodium sulfide substitution/ring closure conditions to provide 4-thio [l]{.smallcaps}-lyxitol **13**. This compound was then oxidized, to give, after a Pummerer rearrangement, the 4-thio lyxosyl donor **2**. The 4-thio-[l]{.smallcaps}-arabinosyl and 4-thio-[l]{.smallcaps}-xylosyl donors **3** and **4** were synthesized using similar transformations starting from commercially available [l]{.smallcaps}-arabinose in similar overall yields ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). With the synthesized 4-thio pentofuranosyl donors (**1**, **2**, **3**, **4**) in hand, the glycosylation reactions were undertaken. All reactions were carried out in dry DCM using TMSOTf as an activator and triethylsilane-*d* (TES-*d*) as a nucleophile. This nucleophile was used as we have previously shown that it can faithfully report on the stereoselectivity of S~N~1-type substitution reactions on glycofuranosyl oxocarbenium ions.^[@ref15],[@ref16]^ Of note, the use of allyl trimethyl silane (TMS-All) as a nucleophile in combination with donor **1** provided the 1-allyl-4-thioribofuranoside with an identical selectivity.

![Synthesis of 4-Thiofuranosyl Donors](jo-2018-025365_0004){#sch2}

The results of the glycosylation reactions are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, alongside the results previously obtained for the *O*-furanosides for comparison. We first probed the reaction of *ribo*-donor **1** and found that a relatively high activation temperature was required (−30 °C with respect to a reaction temperature of −78 °C, for its *oxo* counterpart). Upon reaction with triethylsilane-*d* the 1,2-*cis* addition product was formed selectively (α/β = 91:9). Next the other three donors similarly probed to deliver the results depicted in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and from these it becomes apparent that the stereoselectivities of the reactions of the 4-thiofuranosyl donors parallel those obtained with the *O*-furanosides, but the reactions of the thiodonors are all slightly less selective. In all cases, the 1,2-*cis* products are formed selectively and only the 4-thioxylosyl donor **4** provides a significant amount of the *trans* product.

###### Results of the Substitution Reaction of TES-*d* with the 4-Oxo- and 4-Thiofuranosides

![](jo-2018-025365_0005){#GRAPHIC-d7e546-autogenerated}

                X = O    X = S   
  ------------- -------- ------- -------
  riboside      \>98:2   94:6    91:9
  arabinoside   \<2:98   2:98    8:92
  xyloside      85:15    68:32   69:31
  lyxoside      \<2:98   0:100   3:97

Reagents and conditions: 2 equiv of TES-*d*, 1.3 equiv of TMSOTf, −78 °C, 7 days.

The α/β ratio was established by NMR spectroscopy.

Reagents and conditions: 2 equiv of TES-*d*, 1.3 equiv of TMSOTf, −30 °C, 10 days.

We then set out to investigate the furanosyl thiacarbenium ions using the computational approach we recently used to determine the relative energy of all furanosyl oxocarbenium ion conformers.^[@ref15]^ To this end, we calculated the energies associated with 81 prefixed ring conformations for the thiacarbenium ions. We did so for each of the three C4--C5 rotamers, having the C-5-OMe group in a *tg*, *gg*, or *gt* position (see [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B). Using Gaussian 03, employing the B3LYP hybrid functional and the 6-311G(d,p) basis set, the structures of these (3 × 81 = 243) conformers were optimized and their relative energies calculated. The energies obtained from the DFT calculations were corrected for solvation in DCM by a polarized continuum model (PCM) and subsequently a Gibbs free energy correction was applied at the temperature of the respective experimental glycosylation. The energies of all conformations were then plotted as a polar contour plot on the pseudorotational circle (which describes the complete conformational space of a five-membered ring as a function of the phase angle (*P*) and puckering amplitude (τ~m~),^[@ref19]^ with isoenergetic values as the contour lines, resulting in the conformational energy landscape (CEL) map. (For more information, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.joc.8b02536/suppl_file/jo8b02536_si_001.pdf).) [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} depicts the pseudorotational circle (A) with a set of canonical ring conformations as well as the studied C4--C5 rotamers (B). [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} presents the so-obtained CEL maps for both diastereoisomeric sets of furanosyl thiacarbenium ions and oxocarbenium ions. The CEL maps show that the thiacarbenium ions adopt structures that are very similar to their oxocarbenium ion counterparts and the minimal energy conformers can be found on the ^3^*E*--*E*~3~ axis. The presence of the 4-*S* ring atom does influence the amount of puckering of the five-membered ring going from an approximate puckering of 25° for the oxocarbenium ions to approximately 35° for the thiacarbenium ions, as a result of the larger bond length for the C--S bonds. The maps of the thiacarbenium ions overall show a steeper energy landscape.

![(A) Pseudorotational circle. (B) C4--C5 rotamers in a Newman projection. (C) Two-conformer model as advanced by Woerpel and co-workers.](jo-2018-025365_0002){#fig2}

###### Conformational Energy Landscapes of the 4-Oxo Furanosyl Carbenium Ions and 4-Thio Thiacarbenium Ions

![](jo-2018-025365_0007){#gr5}

Δ*G*~DCM~^T^ represents the relative energy difference between the lowest energy conformer from the given diastereoisomer with respect to the energy of the most stable conformer of the full suite of diastereoisomers.

Looking at the individual stereoisomers, the CEL map of the ribofuranosyl thiacarbenium shows a clear minimum for the *E*~3~ envelope. This structure (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) places all substituents in a position that allows for maximum stabilization of the thiacarbenium ion. As empirically established by Woerpel and co-workers^[@ref20]−[@ref24]^ and supported by previous computational studies,^[@ref15],[@ref16],[@ref25]−[@ref28]^ an oxocarbenium ion is best stabilized by an equatorial OMe substituent at C2 to allow for electron density donation by the axial C2--H2 bond, while the electron density of the ether group at C3 is nearest and most stabilizing to the electron-depleted anomeric center when placed axially. The same holds true for C5-OMe, which is positioned closest to the positive charge, when taking up the axial-*gg*-orientation in the *E*~3~ envelope. The CEL maps reveal that the stereoelectronic "stability rules" that play a decisive role in determining the stability and reactivity of furanosyl oxocarbenium ions equally apply to thiacarbenium ions. A minor population of the ribosyl thiacarbenium ion adopting a ^3^*E* conformation (Δ*G*~DCM~^T^ = 1.3 kcal/mol) can be found. Assuming that the *E*~3~ thiacarbenium ion is preferentially attacked on the α-face and the ^3^*E* structure on the opposite β-side, the Boltzmann-weighed population of both families of conformers predicts a 94:6 α/β selectivity, which closely matches the ratio obtained in the experiment (91:9).

The CEL maps of the arabinosyl and lyxosyl thiacarbenium ion show a clear preference for the ^3^*E* conformer. Nucleophilic attack on this arabinosyl ^3^*E* conformer leads to the selective formation of the β-arabinose anomer, corresponding well with the experimental findings. Similarly, the lyxosyl ^3^*E* conformer is stereoselectively attacked to provide the all-*cis* product. In line with the furanosyl oxocarbenium ion series, the lyxose-configured thiacarbenium shows the strongest preference for a single conformer, which translates into the highest stereoselectivity in the substitution reactions. For the xylofuranosyl thiacarbenium ion, two minima are found on the CEL map, matching the situation for the xylofuranosyl oxocarbenium ion. The difference in energy of the two minima is smaller in the case of the thiacarbenium ion with respect to the oxocarbenium ions and this translates into a lower stereoselectivity of thiofuranosyl donor **4** in the substitution reaction. The Boltzmann-weighed relative population of the *E*~3~ and ^3^*E* conformers predicts a poorly selective glycosylation event, which is closely matched in the experiment. Overall, there is very good agreement between the stereoselectivity that is theoretically predicted based on the CEL maps, in combination with Woerpel's inside attack model and the stereoselectivity obtained experimentally ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). This shows that the relative energy difference between the transition states leading to the products is relatively well approximated using the difference in ground state energy of the thiacarbenium ion conformers and that a Curtin--Hammett kinetic scenario, in which the lowest energy transition state is reached from a higher energy ground state species, plays a very minor role. The correlation between the reaction stereoselectivity and the thiacarbenium ion structure strongly indicates the thiacarbenium ions to be the product-forming reactive intermediates in these reactions.

Finally, we investigated the difference in reactivity between the C4-*S* and C4-*O* donors in a set of direct competition glycosylation experiments ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). In the first set of experiments, the 4-*S*-ribosyl and 4-*O*-ribosyl^[@ref15]^ donors, **1** and **29**, were mixed and exposed to reaction conditions, in which the quantity of the activator (TMSOTf) or acceptor (TES-*d*) was varied to investigate whether either of the two substrates is activated more easily or if the resulting oxo- or thiacarbenium ion intermediate is more reactive toward nucleophiles ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entries 1--3). All experiments showed that the 4-thio ribofuranosyl donor reacts more slowly than its 4-oxo counterpart. For all other furanosides, the 4-thio donors reacted faster and only the 1-[d]{.smallcaps} products derived from these donors were formed. The striking difference in relative reactivity may be explained by the relative stability of the intermediate thia and oxo carbenium ions. In [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, the relative energy difference between the different diasteroisomeric CEL maps is depicted. The difference in energy between the lowest energy conformer of the individual diastereoisomers with respect to the most stable diasteroisomeric oxocarbenium ion is Δ*G*~DCM~^T^*ribo* = 0 kcal/mol; Δ*G*~DCM~^T^*ara* = 0.1 kcal/mol; Δ*G*~DCM~^T^*xylo* = 0.9 kcal/mol; Δ*G*~DCM~^T^*lyxo* = 0.2 kcal/mol. Thus, in the oxo series, the ribose oxocarbenium is most stable, closely followed by the arabinose and lyxose ions, with the xylose oxocarbenium ion clearly being the least stable. The situation is rather different in the thio series. Here the order of stability is arabinose (Δ*G*~DCM~^T^*Ara* = 0 kcal/mol) \> lyxose (Δ*G*~DCM~^T^*lyxo* = 0.2 kcal/mol) \> ribose (Δ*G*~DCM~^T^*ribo* = 1.4 kcal/mol) ∼ xylose (Δ*G*~DCM~^T^*xylo* = 1.4 kcal/mol). In this case, the ribo-thiacarbenium ion appears to be one of the least stable of the series. Overall, this data suggests that the formation of the *ribo*-thiacarbenium ion when compared to the formation of the corresponding oxocarbenium ion is relatively difficult, providing an explanation for the relatively low reactivity of donor **1** with respect to donor **29**.

###### Results of the Substitution Reaction of TES-*d* with the 4-Oxo and 4-Thiofuranosides[a](#tbl3-fn1){ref-type="table-fn"}

  entry   O donor            S donor           acceptor            activator          conditions        product ratio[b](#t3fn1){ref-type="table-fn"} S/O
  ------- ------------------ ----------------- ------------------- ------------------ ----------------- ---------------------------------------------------
  1       **29** (1 equiv)   **1** (1 equiv)   TES-*d* (2 equiv)   TMSOTf (2 equiv)   --30 °C, 2 days   1:4
  2       **29** (1 equiv)   **1** (1 equiv)   TES-*d* (1 equiv)   TMSOTf (2 equiv)   --30 °C, 2 days   1:4
  3       **29** (1 equiv)   **1** (1 equiv)   TES-*d* (2 equiv)   TMSOTf (1 equiv)   --30 °C, 2 days   1:3.5
  4       **31** (1 equiv)   **2** (1 equiv)   TES-*d* (1 equiv)   TMSOTf (2 equiv)   --30 °C, 2 days   1:0
  5       **33 **(1 equiv)   **3** (1 equiv)   TES-*d* (1 equiv)   TMSOTf (2 equiv)   --30 °C, 2 days   1:0
  6       **35 **(1 equiv)   **4** (1 equiv)   TES-*d* (1 equiv)   TMSOTf (2 equiv)   --30 °C, 2 days   1:0

Competition experiments screening the reactivity of 4-oxo pentofuranosyl donors relative to 4-thio pentofuranosyl donors.

The product ratio was established by NMR spectroscopy and isolated mass of products.

Conclusions {#sec3}
===========

In conclusion, we have performed an in-depth investigation into the stability/reactivity of furanosyl thiacarbenium ions, assessing all four diastereoisomeric thiofuranosides experimentally and computationally to show that all furanosyl thiacarbenium ions react in a 1,2-*cis*-selective manner. There is a clear correlation to the stereoselectivity of 4-oxofuranosides, with the cationic intermediates taking up similar structures. From these results, it can be concluded that the substitution reactions follow similar reaction paths. Interestingly, differences in relative reactivity were observed for the reactivity of the 4-thio donors with respect to their oxo counterparts. While the *ribo*-configured 4-thio furanose is less reactive than the corresponding 4-*O*-furanoside, the other three diastereoisomeric 4-thio donors are more reactive than the parent 4-oxofuranosides. The relative reactivity of the *ribo*-furanosides thus follows the reactivity difference observed for the acyclic benzylic thia/oxocarbenium ions studied by Jagannadham et al.,^[@ref14]^ while the reactivity of the *arabino*, *xylo*, and *lyxo* species are in line with the relative reactivity of 5-thio/oxo pyranosides. The similar but lower reactivity of 4-thioribofuranosides supports their use as stable and close mimics of the naturally occurring ribofuranosides. Finally, the results presented here show that the model for rationalizing the stereoselectivity of addition reactions to oxocarbenium ions can be extended to other nontypical glycosyl carbocations, providing further support for the model and the relevance of the reactive intermediates.

Experimental Section {#sec4}
====================

General {#sec4.1}
-------

All solvents used under anhydrous conditions were stored over 4 Å molecular sieves, except for methanol, which was stored over 3 Å molecular sieves. Solvents used for workup and column chromatography were of technical grade from Sigma-Aldrich and used directly. Unless stated otherwise, solvents were removed by rotary evaporation under reduced pressure at 40 °C. Reactions were monitored by TLC analysis using Merck 25 DC plastikfolien 60 F254 with detection by spraying with 20% H~2~SO~4~ in EtOH, (NH~4~)~6~Mo~7~O~24~·4H~2~O (25 g/L), and (NH~4~)~4~Ce(SO~4~)~4~·2H~2~O (10 g/L) in 10% sulfuric acid or by spraying with a solution of ninhydrin (3 g/L) in EtOH/AcOH (20:1 v/v), followed by charring at approximately 150 °C. Column chromatography was performed on Fluka silica gel (0.04--0.063 mm) or by automation using a Biotage Isolera Spektra Four machine. For LC--MS analysis, a JASCO HPLC system (detection simultaneously at 214 and 254 nm) equipped with an analytical C18 column (4.6 mm *D* × 50 mm *L*, 3 μ particle size) in combination with buffers A (H~2~O), B (MeCN), and C (0.5% aq TFA) and coupled to a PE/SCIEX API 165 single quadruple mass spectrometer (PerkinElmer) was used, unless stated otherwise. Alternatively, a Thermo Finnigan LCQ Advantage MAX ion-trap mass spectrometer with an electrospray ion source coupled to a Surveyor HPLC system (Thermo Finnegan) was used with the same analytical column. High-resolution mass spectra were recorded by direct injection (2 μL of a 2 μM solution in water/acetonitrile; 50:50; v/v and 0.1% formic acid) on a mass spectrometer (Thermo Finnigan LTQ Orbitrap) equipped with an electrospray ion source in positive mode (source voltage 3.5 kV, sheath gas flow 10, capillary temperature 250 °C) with a resolution (*R*) = 60 000 at *m*/*z* 400 (mass range *m*/*z* = 150 2000) and dioctylpthalate (*m*/*z* = 391.2842) as a "lock mass". The high-resolution mass spectrometer was calibrated prior to measurements with a calibration mixture (Thermo Finnigan). ^1^H and ^13^C NMR spectra were measured on a Bruker AV 400 (400 MHz) or a Bruker DMX 600 (600 MHz), and all individual signals were assigned using 2D NMR spectroscopy. Chemical shifts are given in ppm (δ) relative to TMS (0 ppm), and coupling constants (*J*) are given in hertz (Hz). Optical rotations were measured in CHCl~3~ or methanol at a concentration of 10 mg/mL at 25 °C. Stereoisomers were, when possible, separated by silica gel column chromatography for analytical purposes.

### Synthesis and Characterization {#sec4.1.1}

#### Methyl α,β-[d]{.smallcaps}-Ribofuranoside (**5**) {#sec4.1.1.1}

![](jo-2018-025365_0009){#gr6}

[d]{.smallcaps}-Ribose (15.0 g, 100 mmol) was dissolved in methanol (250 mL). The solution was cooled to 0 °C, and sulfuric acid (0.27 mL, 5 mmol) was slowly added. The reaction mixture was stirred for 24 h at 4 °C. The reaction was quenched upon the addition of sodium bicarbonate. The reaction mixture was filtered, concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.25 (CHCl~3~/EtOAc/MeOH, 63:25:12).

#### Methyl 2,3,5-Tri-*O*-benzyl-α,β-[d]{.smallcaps}-ribofuranoside (**6**) {#sec4.1.1.2}

![](jo-2018-025365_0010){#gr7}

Crude **5** (100 mmol) was dissolved in DMF (400 mL). The mixture was cooled to 0 °C, and sodium hydride (350 mmol, 8.40 g, 60% in mineral oil) was slowly added. After hydrogen gas formation stopped, benzyl bromide (350 mmol, 41.6 mL) was slowly added, and the reaction mixture was stirred at room temperature for 5 h. The reaction was quenched by the addition of ice. The reaction mixture was diluted with EtOAc and washed with water and brine. The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.35 (EtOAc/pentane, 5:95).

#### 2,3,5-Tri-*O*-benzyl-α,β-[d]{.smallcaps}-ribose (**7**) {#sec4.1.1.3}

![](jo-2018-025365_0011){#gr8}

Crude **6** (100 mmol) was dissolved in formic acid (800 mL) and water (200 mL), and the mixture was stirred at 60 °C for 18 h. The reaction mixture was diluted with diethyl ether, and the organic layer was washed with water and aq NaHCO~3~ (sat.), dried (MgSO~4~), and concentrated in vacuo, and column chromatography (pentane/EtOAc, 95:5 to 70:30) yielded the title compound (36.2 g, 86.2 mmol, 86% over three steps). Spectroscopic data was in agreement with literature.^[@ref15]^

#### (2*S*,3*R*,4*R*)-2,3,5-Tri-*O*-benzyl-pentane-1,4-diol (**8**) {#sec4.1.1.4}

![](jo-2018-025365_0012){#gr9}

Compound **7** (21.5 mmol) was dissolved in methanol (110 mL), and sodium borohydride (43 mmol, 1.63 g) was added in small portions over a period of 30 min at 0 °C. The reaction was then stirred for 1 h at room temperature, after which the solvent was removed in vacuo. The residue was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.55 (EtOAc/pentane, 40:60).

#### (2*S*,3*S*,4*R*)-2,3,5-Tri-*O*-benzyl-pentane-1,4-dimesylate (**9**) {#sec4.1.1.5}

![](jo-2018-025365_0013){#gr10}

Crude **8** (21.5 mmol) was dissolved in DCM (110 mL), and triethylamine (86 mmol, 12.0 mL) was added. Mesyl chloride (64.5 mmol, 5.0 mL) was slowly added at −20 °C, and the reaction was stirred for 30 min, after which it was quenched upon the addition of ice. The organic layer was washed with water, aq NaHCO~3~ (sat.), and brine, dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.60 (EtOAc/pentane, 30:70).

#### (2*R*,3*S*,4*S*)-2,3,5-*O*-Tribenzyl-1,4-dibromopentane (**10**) {#sec4.1.1.6}

![](jo-2018-025365_0014){#gr11}

Crude **9** (38.4 mmol), coevaporated with toluene to remove traces of water, was dissolved in dry 2-butanone (130 mL). Lithium bromide (384 mmol, 33.4 g) was added, and the reaction was refluxed for 16 h. The reaction mixture was diluted with EtOAc and washed with water, aq NaHCO~3~ (sat.), and brine. The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.55 (EtOAc/pentane, 5:95).

#### 1,4-Anhydro-2,3,5-*O*-tribenzyl-4-thio-[d]{.smallcaps}-ribitol (**11**) {#sec4.1.1.7}

![](jo-2018-025365_0015){#gr12}

Crude **10** (38.4 mmol) and sodium sulfide nonahydrate (46.1 mmol, 11.1 g) were dissolved in DMF (130 mL). The reaction mixture was stirred at 100 °C for 30 min. The residue was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (24.0 mmol, 10.1 g, 63% over 4 steps): ^1^H NMR (600 MHz, CDCl~3~) δ 7.59--7.13 (m, 15H), 4.64--4.38 (m, 6H), 3.99 (ddd, *J* = 6.9, 5.4, 3.4 Hz, 1H), 3.93 (dd, *J* = 4.8, 3.5 Hz, 1H), 3.67 (td, *J* = 6.6, 4.6 Hz, 1H), 3.45 (AB, *J* = 10.0, 6.5 Hz, 2H), 3.00 (AB, *J* = 10.7, 6.8 Hz, 1H), 2.84 (AB, *J* = 10.7, 5.4 Hz, 1H); ^13^C{^1^H} NMR (151 MHz, CDCl~3~) δ 138.0, 137.9, 137.9, 128.3, 128.3, 128.2, 127.8, 127.6, 127.6, 127.5, 127.5, 80.8, 79.5, 72.9, 71.8, 71.7, 71.6, 47.0, 30.5; IR (neat) 3029, 2932, 2857, 1496, 1453, 1112, 1070, 1027, 732, 694 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~28~O~3~SNa 443.1644, found 443.1651; \[α\]~D~^20^ (*c* 2, DCM) +64.6; *R*~*f*~ = 0.35 (EtOAc/pentane, 5:95). Spectroscopic data was in agreement with literature.^[@ref29]^

#### 1,4-Anhydro-2,3,5-tri-*O*-benzyl-4-sulfoxide-[d]{.smallcaps}-ribitol (**12**) {#sec4.1.1.8}

![](jo-2018-025365_0016){#gr13}

Compound **11** (15.7 mmol, 6.61 g) was dissolved in DCM (100 mL), and *m*-CPBA (17.3 mmol, 3.00 g) was added at −40 °C. The reaction mixture was stirred for 1 h. The reaction mixture was quenched by the addition of aq Na~2~S~2~O~3~ (sat.), and the organic layer was washed with aq NaHCO~3~ (sat.). The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.05 (EtOAc/pentane, 30:70).

#### 1-*O*-Acetyl-2,3,5-tri-*O*-benzyl-4-thio-α,β-[d]{.smallcaps}-ribofuranose (**1**) {#sec4.1.1.9}

![](jo-2018-025365_0017){#gr14}

Crude **12** (15.7 mmol) was dissolved in acetic anhydride (100 mL), and the mixture was stirred at 100 °C for 3 h. The reaction mixture was concentrated in vacuo, and column chromatography (pentane/EtOAc, 90:10 to 80:20) yielded the title compound (11.3 mmol, 5.4 g, 72% over two steps): ^1^H NMR (500 MHz, CDCl~3~) δ 7.44--7.14 (m, 15H), 6.21 (d, *J* = 4.7 Hz, 1H), 5.97 (d, *J* = 2.0 Hz), 4.78--4.39 (m, 6H, CH~2~ Bn), 4.11 (dd, *J* = 4.1, 2.2 Hz, 1H), 4.07 (dd, *J* = 3.5, 2.0 Hz, 1H), 4.05--4.00 (m, 1H), 3.98 (dd, *J* = 8.4, 3.5 Hz, 1H), 3.88--3.82 (m, 1H), 3.81--3.72 (m, 2H), 3.59 (AB, *J* = 9.8, 6.9 Hz, 1H), 3.39 (AB, *J* = 10.0, 5.4 Hz, 1H), 3.31 (AB, *J* = 10.0, 7.7 Hz, 1H), 2.12 (s, 3H), 2.02 (s, 3H); ^13^C{^1^H} NMR (126 MHz, CDCl~3~) δ 171.0, 169.9, 138.4, 138.2, 137.82, 137.8, 137.7, 137.7, 128.5, 128.5, 128.5, 128.4, 128.3, 128.0, 128.0, 127.9, 127.9, 127.9, 127.8, 127.7, 127.7, 127.6, 81.3, 81.2, 80.9, 80.6, 79.9, 77.0, 73.2, 72.9, 72.9, 72.8, 72.2, 72.1, 72.0, 71.7, 71.5, 48.5, 47.9, 21.5, 21.2; IR (neat) 3064, 3030, 2939, 2865, 1733, 1496, 1454, 1366, 1265, 1225, 1102, 1027, 1016, 957, 731, 695 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~28~H~30~O~5~SNa 501.1706, found 501.1700; *R*~*f*~ = 0.40 (EtOAc/pentane, 15:85).

#### 1,4-Anhydro-2,3,5-*O*-tribenzyl-4-thio-[l]{.smallcaps}-lyxitol (**13**) {#sec4.1.1.10}

![](jo-2018-025365_0018){#gr15}

Crude **9** (12.1 mmol, 6.98 g) and sodium sulfide nonahydrate (13.3 mmol, 3.18 g) were dissolved in DMF (120 mL). The reaction mixture was stirred at 100 °C for 2 h. The mixture was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (5.2 mmol, 2.2 g, 43% over 3 steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.38--7.22 (m, 15H), 4.86 (d, *J* = 11.7 Hz, 1H), 4.68 (d, *J* = 11.8 Hz, 1H), 4.53 (m, 4H), 4.20 (dd, *J* = 4.1, 2.8 Hz, 1H), 4.10--3.99 (m, 1H), 3.90 (dd, *J* = 8.4, 7.0 Hz, 1H), 3.64--3.50 (m, 2H), 3.06 (t, *J* = 9.4 Hz, 1H), 2.91 (dd, *J* = 9.8, 6.1 Hz, 1H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.7, 138.2, 128.6, 128.5, 128.4, 127.9, 127.8, 127.8, 127.7, 127.5, 83.6, 78.9, 73.7, 73.4, 72.3, 70.3, 45.8, 30.5; IR (neat) 3087, 3062, 3029, 2931, 2859, 1496, 1453, 1360, 1207, 1086, 1068, 1027, 732, 695 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~28~O~3~SNa 443.1644, found 443.1658; \[α\]~D~^20^ (*c* 1, DCM) −7.0; *R*~*f*~ = 0.30 (EtOAc/pentane, 5:95). Spectroscopic data was in agreement with literature.^[@ref18]^

#### 1,4-Anhydro-2,3,5-tri-*O*-benzyl-4-sulfoxide-[l]{.smallcaps}-lyxitol (**14**) {#sec4.1.1.11}

![](jo-2018-025365_0019){#gr16}

Compound **13** (4.4 mmol, 1.84 g) was dissolved in DCM (45 mL), and *m*-CPBA (4.8 mmol, 0.83 g) was added at −40 °C. The reaction mixture was stirred for 1 h. The reaction mixture was quenched by the addition of aq Na~2~S~2~O~3~ (sat.), and the organic layer was washed with aq NaHCO~3~ (sat.). The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.05 (EtOAc/pentane, 30:70).

#### 1-*O*-Acetyl-2,3,5-tri-*O*-benzyl-4-thio-α,β-[l]{.smallcaps}-lyxofuranose (**2**) {#sec4.1.1.12}

![](jo-2018-025365_0020){#gr17}

Crude **14** (4.4 mmol) was dissolved in acetic anhydride (30 mL), and the mixture was stirred at 100 °C for 5 h. The reaction mixture was concentrated in vacuo, and column chromatography (pentane/EtOAc, 90:10 to 80:20) yielded the title compound (1.34 mmol, 0.64 g, 31% over two steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.45--7.24 (m, 15H), 6.01 (d, *J* = 3.7 Hz, 1H), 4.73--4.45 (m, 6H), 4.31--4.28 (m, 1H), 4.27--4.21 (m, 1H), 4.10 (t, *J* = 3.5 Hz, 1H), 4.00--3.91 (m, 3H), 3.78 (dt, *J* = 7.9, 5.6 Hz, 1H), 3.69 (dd, *J* = 9.2, 7.9 Hz, 1H), 3.62--3.47 (m, 2H), 2.09 (s, 3H), 2.04 (s, 3H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.1, 137.8, 128.7, 128.5, 128.5, 128.5, 128.3, 128.1, 127.9, 127.9, 127.8, 127.8, 127.7, 127.6, 127.5, 84.5, 84.2, 80.7, 79.5, 78.6, 76.0, 73.6, 73.5, 73.4, 72.7, 72.5, 71.2, 69.7, 46.5, 46.3, 21.5, 21.2; IR (neat) 3078, 3064, 3030, 2923, 2864, 1735, 1496, 1453, 1366, 1309, 1224, 1094, 1061, 1016, 957, 910, 733, 695 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~28~H~30~O~5~SNa 501.1706, found 501.1714; *R*~*f*~ = 0.45 (EtOAc/pentane, 15:85).

#### Methyl α,β-[l]{.smallcaps}-Aarabinofuranoside (**15**) {#sec4.1.1.13}

![](jo-2018-025365_0021){#gr18}

[l]{.smallcaps}-Arabinose (100 mmol, 15.0 g) was dissolved in methanol (250 mL). The solution was cooled to 0 °C, and sulfuric acid (5 mmol, 0.27 mL) was slowly added. The reaction mixture was stirred for 4 nights at room temperature. The reaction was quenched upon the addition of sodium bicarbonate. The reaction mixture was filtered, concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.30 (CHCl~3~/EtOAc/MeOH, 63:25:12).

#### Methyl 2,3,5-Tri-*O*-benzyl-α,β-[l]{.smallcaps}-arabinofuranoside (**16**) {#sec4.1.1.14}

![](jo-2018-025365_0022){#gr19}

Crude **15** (100 mmol) was dissolved in DMF (350 mL), and the mixture was cooled to 0 °C. Sodium hydride (350 mmol, 14.0 g, 60% in mineral oil) was slowly added. After hydrogen gas formation stopped, benzyl bromide (350 mmol, 41.6 mL) was slowly added, and the reaction mixture was stirred at room temperature for 3 h. The reaction was quenched by the addition of ice. The reaction mixture was diluted with diethyl ether and washed with water and brine. The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.25 (EtOAc/pentane, 5:95).

#### 2,3,5-Tri-*O*-benzyl-α,β-[l]{.smallcaps}-arabinose (**17**) {#sec4.1.1.15}

![](jo-2018-025365_0023){#gr20}

Crude **16** (100 mmol) was dissolved in formic acid (800 mL) and water (200 mL), and the mixture was stirred at 60 °C for 18 h. The reaction mixture was extracted with DCM, and the organic layer was washed with water and aq NaHCO~3~ (sat.), dried (MgSO~4~), and concentrated in vacuo. Column chromatography (pentane/EtOAc, 95:5 to 70:30) yielded the title compound (27.2 g, 65.6 mmol, 66% over three steps). Spectroscopic data was in agreement with literature.^[@ref15]^

#### (2*S*,3*S*,4*S*)-2,3,5-Tri-*O*-benzyl-pentane-1,4-diol (**18**) {#sec4.1.1.16}

![](jo-2018-025365_0024){#gr21}

Compound **17** (64.0 mmol, 26.9 g) was dissolved in methanol (320 mL), and sodium borohydride (134 mmol, 5.1 g) was added in small portions over a period of 30 min at 0 °C. The reaction was then stirred for 1.5 h at room temperature, after which the solvent was removed in vacuo. The residue was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.45 (EtOAc/pentane, 40:60).

#### (2*S*,3*R*,4*S*)-2,3,5-Tri-*O*-benzyl-pentane-1,4-dimesylate (**19**) {#sec4.1.1.17}

![](jo-2018-025365_0025){#gr22}

Crude **18** (64 mmol) was dissolved in DCM (300 mL), and triethylamine (256 mmol, 36.0 mL) was added. Mesyl chloride (192 mmol, 15.0 mL) was slowly added at −20 °C, and the reaction was stirred for 30 min, after which it was quenched upon the addition of ice. The organic layer was washed with water, aq NaHCO~3~ (sat.), and brine, dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.45 (EtOAc/pentane, 30:70).

#### (2*R*,3*R*,4*R*)-2,3,5-*O*-Tribenzyl-1,4-dibromopentane (**20**) {#sec4.1.1.18}

![](jo-2018-025365_0026){#gr23}

Crude **19** (27.2 mmol), coevaporated with toluene to remove traces of water, was dissolved in dry 2-butanone (100 mL). Lithium bromide (226 mmol, 19.6 g) was added, and the reaction was refluxed for 20 h. The reaction mixture was diluted with EtOAc and washed with water, aq NaHCO~3~ (sat.), and brine. The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.60 (EtOAc/pentane, 5:95).

#### 1,4-Anhydro-2,3,5-*O*-tribenzyl-4-thio-[l]{.smallcaps}-arabitol (**21**) {#sec4.1.1.19}

![](jo-2018-025365_0027){#gr24}

Crude **20** (27.2 mmol) and sodium sulfide nonahydrate (24.9 mmol, 6.0 g) were dissolved in DMF (220 mL). The reaction mixture was stirred at 100 °C for 30 min. The residue was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (13.6 mmol, 5.7 g, 50% over 4 steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.39--7.22 (m, 15H), 4.61 (s, 2H), 4.54--4.45 (m, 4H), 4.19 (q, *J* = 4.6 Hz, 1H), 4.11 (t, *J* = 3.7 Hz, 1H), 3.68 (dd, *J* = 8.9, 7.6 Hz, 1H), 3.61--3.44 (m, 2H), 3.07 (dd, *J* = 11.3, 5.1 Hz, 1H), 2.90 (dd, *J* = 11.4, 4.6 Hz, 1H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.2, 138.0, 128.6, 128.5, 128.5, 128.0, 127.9, 127.8, 127.8, 127.7, 85.2, 73.2, 72.5, 72.0, 71.6, 49.1, 33.3; IR (neat) 3087, 3063, 3029, 2932, 2861, 1496, 1362, 1207, 1093, 1070, 1028, 735, 696 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~28~O~3~SNa 443.1644, found 443.1656; \[α\]~D~^20^ (*c* 0.5, DCM) +9.7; *R*~*f*~ = 0.45 (EtOAc/pentane, 5:95). Spectroscopic data was in agreement with literature.^[@ref30]^

#### 1,4-Anhydro-2,3,5-tri-*O*-benzyl-4-sulfoxide-[l]{.smallcaps}-arabitol (**22**) {#sec4.1.1.20}

![](jo-2018-025365_0028){#gr25}

Compound **21** (1.73 mmol, 0.73 g) was dissolved in DCM (15 mL), and *m*-CPBA (1.91 mmol, 0.33 g) was added at −40 °C. The reaction mixture was stirred for 2 h. The reaction mixture was quenched by the addition of aq Na~2~S~2~O~3~ (sat.), and the organic layer was washed with aq NaHCO~3~ (sat.). The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.05 (EtOAc/pentane, 30:70).

#### 1-*O*-Acetyl-2,3,5-tri-*O*-benzyl-4-thio-α,β-[l]{.smallcaps}-arabinofuranose (**3**) {#sec4.1.1.21}

![](jo-2018-025365_0029){#gr26}

Crude **22** (1.73 mmol) was dissolved in acetic anhydride (15 mL), and the mixture was stirred at 100 °C for 3 h. The reaction mixture was concentrated in vacuo, and column chromatography (pentane/EtOAc, 90:10 to 80:20) yielded the title compound (0.88 mmol, 0.42 g, 51% over two steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.41--7.23 (m, 15H), 6.11 (d, *J* = 4.0 Hz, 1H), 6.02 (d, *J* = 3.0 Hz, 1H), 4.86--4.50 (m, 6H), 4.30 (dd, *J* = 5.2, 3.1 Hz, 1H), 4.27--4.12 (m, 2H), 4.07 (dd, *J* = 6.5, 5.2 Hz, 1H), 3.81 (q, *J* = 6.4 Hz, 1H), 3.77--3.68 (m, 2H), 3.59--3.39 (m, 3H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.4, 138.0, 137.6, 128.6, 128.6, 128.5, 128.5, 128.1, 128.1, 128.0, 128.0, 127.9, 127.9, 127.8, 127.8, 88.9, 86.1, 84.7, 83.9, 82.1, 74.8, 73.6, 73.3, 73.3, 73.2, 72.9, 72.8, 72.7, 71.0, 49.5, 45.4, 21.5, 21.3; IR (neat) 3088, 3063, 3031, 2926, 2863, 1793, 1496, 1453, 1367, 1226, 1098, 1074, 1017, 734, 695 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~28~H~30~O~5~SNa 501.1706, found 501.1713; *R*~*f*~ = 0.25 (EtOAc/pentane, 10:90). Spectroscopic data was in agreement with literature.^[@ref31]^

#### 1,4-Anhydro-2,3,5-*O*-tribenzyl-4-thio-[d]{.smallcaps}-xylitol (**23**) {#sec4.1.1.22}

![](jo-2018-025365_0030){#gr27}

Crude **20** (10.4 mmol) and sodium sulfide nonahydrate (10.5 mmol, 2.5 g) were dissolved in DMF (40 mL). The reaction mixture was stirred at 100 °C for 4 h. The residue was dissolved in EtOAc, washed with water and brine, dried (MgSO~4~), and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (4.9 mmol, 2.0 g, 47% over 3 steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.23 (m, 15H), 4.61--4.45 (m, 6H), 4.14 (m, 2H), 3.89--3.79 (m, 2H), 3.68--3.57 (m, 1H), 3.11 (dd, *J* = 11.4, 4.4 Hz, 1H), 2.85 (dd, *J* = 11.5, 2.3 Hz, 1H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.2, 138.1, 128.6, 128.5, 128.5, 127.9, 127.9, 127.9, 127.8, 127.7, 127.7, 83.1, 73.4, 72.8, 71.4, 69.4, 48.1, 33.2; IR (neat) 3087, 3062, 3030, 2935, 2860, 1497, 1453, 1392, 1361, 1313, 1271, 1207, 1087, 1070, 1027, 733, 695; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~28~O~3~SNa 443.1644, found 443.1657; \[α\]~D~^20^ (*c* 1, DCM) +52.2; *R*~*f*~ = 0.60 (EtOAc/pentane, 10:90).

#### 1,4-Anhydro-2,3,5-tri-*O*-benzyl-4-sulfoxide-[d]{.smallcaps}-xylitol (**24**) {#sec4.1.1.23}

![](jo-2018-025365_0031){#gr28}

Compound **23** (4.8 mmol, 2.0 g) was dissolved in DCM (40 mL), and *m*-CPBA (5.3 mmol, 0.9 g) was added at −40 °C. The reaction mixture was stirred for 2 h. The reaction mixture was quenched by the addition of aq Na~2~S~2~O~3~ (sat.), and the organic layer was washed with aq NaHCO~3~ (sat.). The organic layer was dried (MgSO~4~), concentrated in vacuo, and used in the next step without further purification. *R*~*f*~ = 0.05 (EtOAc/pentane, 30:70).

#### 1-*O*-Acetyl-2,3,5-tri-*O*-benzyl-4-thio-α,β-[d]{.smallcaps}-xylofuranose (**4**) {#sec4.1.1.24}

![](jo-2018-025365_0032){#gr29}

Crude **24** (4.8 mmol) was dissolved in acetic anhydride (30 mL), and the mixture was stirred at 80 °C for 16 h. The reaction mixture was concentrated in vacuo, and column chromatography (pentane/EtOAc, 90:10 to 80:20) yielded the title compound (2.0 mmol, 0.96 g, 42% over two steps): ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.24 (m, 15H), 6.07 (d, *J* = 4.5 Hz, 1H), 5.94 (d, *J* = 2.7 Hz, 1H), 4.80--4.54 (m, 6H), 4.39--4.25 (m, 2H), 4.29--4.12 (m, 2H), 3.98--3.83 (m, 1H), 3.79 (dd, *J* = 9.6, 4.7 Hz, 1H), 3.74--3.64 (m, 3H), 3.53 (dd, *J* = 9.6, 7.5 Hz, 1H), 2.09 (s, 3H), 2.00 (s, 3H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.2, 138.2, 137.9, 137.8, 137.8, 128.6, 128.5, 128.5, 128.4, 128.0, 128.0, 127.9, 127.9, 127.8, 127.8, 127.8, 127.7, 127.7, 127.7, 127.7, 86.6, 83.3, 83.1, 82.1, 81.6, 73.7, 73.5, 73.5, 73.2, 72.7 72.5, 71.0, 69.8, 48.1, 42.1, 21.4, 21.2; IR (neat) 3063, 3031, 2927, 2863, 1738, 1496, 1454, 1367, 1227, 1093, 1017, 932, 735, 696 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~28~H~30~O~5~SNa 501.1706, found 501.1713; *R*~*f*~ = 0.45 (EtOAc/pentane, 10:90). Spectroscopic data was in agreement with literature.^[@ref32]^

#### 1-Deutero-2,3,5-tri-*O*-benzyl-4-thio-[d]{.smallcaps}-ribitol (**25**) {#sec4.1.1.25}

![](jo-2018-025365_0033){#gr30}

Donor **1** (0.10 mmol, 0.046 g), dried by coevaporating with dry toluene (3×), was dissolved in dry DCM (3.22 mL), and the mixture was stirred with freshly activated 3 Å molecular sieves at room temperature for 1 h under argon to remove traces of water. The solution was then cooled to −78 °C, and TES-*d* (0.19 mmol), dissolved in DCM (0.38 mL), was added followed by the addition of TMSOTf (0.12 mmol), dissolved in DCM (0.24 mL). Next, the reaction mixture was stirred at −30 °C for 10 days and quenched by the addition of TEA (0.5 mL). The reaction mixture was filtered through a path of Celite and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (0.029 g, 0.07 mmol, 72%, α/β = 91:9): ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.23 (m, 15H), 4.64--4.46 (m, 6H), 4.02 (dd, *J* = 5.4, 3.5 Hz, 1H), 3.95 (t, *J* = 4.0 Hz, 1H), 3.68 (td, *J* = 6.4, 4.4 Hz, 1H), 3.54--3.41 (m, 2H), 3.02 (d, *J* = 6.8 Hz, 0.09H), 2.87 (d, *J* = 5.3 Hz, 0.91H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.2, 138.2, 138.1, 128.5, 128.4, 128.1, 127.8, 127.8, 81.0, 79.7, 73.1, 72.0, 72.0, 71.9, 47.3, 30.5 (t); IR (neat) 3088, 3064, 3030, 2924, 2863, 1497, 1454, 1362, 1207, 1107, 1046, 1027, 763, 697 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~27~DO~3~SNa 444.1720, found 444.1720; \[α\]~D~^20^ (*c* 0.5, DCM) +28.2.

#### 1-Deutero-2,3,5-tri-*O*-benzyl-4-thio-[l]{.smallcaps}-lyxitol (**26**) {#sec4.1.1.26}

![](jo-2018-025365_0034){#gr31}

Donor **2** (0.17 mmol, 0.080 g), dried by coevaporating with dry toluene (3×), was dissolved in dry DCM (5.3 mL) and stirred with freshly activated 3 Å molecular sieves at room temperature for 1 h under argon to remove traces of water. The solution was then cooled to −78 °C, and TES-*d* (0.34 mmol), dissolved in DCM (0.68 mL), was added followed by the addition of TMSOTf (0.22 mmol), dissolved in DCM (0.44 mL). Next, the reaction mixture was stirred at −30 °C for 10 days and quenched by the addition of TEA (0.5 mL). The reaction mixture was filtered through a path of Celite and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (0.028 g, 0.07 mmol, 41%, α/β = 3:97): ^1^H NMR (400 MHz, CDCl~3~) δ 7.39--7.22 (m, 15H), 4.86 (d, *J* = 11.7 Hz, 1H), 4.68 (d, *J* = 11.8 Hz, 1H), 4.57 (s, 2H), 4.49 (s, 2H), 4.20 (dd, *J* = 4.0, 2.9 Hz, 1H), 4.03 (dd, *J* = 6.1, 2.9 Hz, 1H), 3.99--3.82 (m, 1H), 3.63--3.50 (m, 2H), 3.04 (dd, *J* = 10.3, 3.7 Hz, 0.07H), 2.89 (d, *J* = 6.1 Hz, 0.93H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.8, 138.3, 138.2, 128.6--127.5, 83.6, 78.9, 73.7, 73.4, 72.3, 70.3, 45.8, 30.2 (t); IR (neat) 3066, 3033, 2922, 2860, 1454, 1269, 1112, 1027, 738, 698, 668 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~27~DO~3~SNa 444.1720, found 444.1720; \[α\]~D~^20^ (*c* 1, DCM) +1.0.

#### 1-Deutero-2,3,5-tri-*O*-benzyl-4-thio-[l]{.smallcaps}-arabitol (**27**) {#sec4.1.1.27}

![](jo-2018-025365_0035){#gr32}

Donor **3** (0.16 mmol, 0.075 g), dried by coevaporating with dry toluene (3×), was dissolved in dry DCM (5.3 mL) and stirred with freshly activated 3 Å molecular sieves at room temperature for 1 h under argon to remove traces of water. The solution was then cooled to −78 °C and TES-*d* (0.32 mmol), dissolved in DCM (0.64 mL), was added followed by the addition of TMSOTf (0.21 mmol), dissolved in DCM (0.42 mL). Next, the reaction mixture was stirred at −30 °C for 10 days and quenched by the addition of TEA (0.5 mL). The reaction mixture was filtered through a path of Celite and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (0.046 g, 0.11 mmol, 68%, α/β = 8:92): ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.23 (m, 15H), 4.61 (s, 2H), 4.58--4.43 (m, 4H), 4.22--4.14 (m, 1H), 4.11 (t, *J* = 3.7 Hz, 1H), 3.68 (dd, *J* = 8.9, 7.5 Hz, 1H), 3.56 (td, *J* = 7.3, 6.8, 3.4 Hz, 1H), 3.50 (dd, *J* = 8.9, 6.2 Hz, 1H), 3.06 (d, *J* = 5.1 Hz, 0.91H), 2.89 (d, *J* = 4.2 Hz, 0.09H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.2, 138.0, 128.8--127.7, 85.1, 73.2, 72.6, 72.0, 71.6, 49.1, 33.0 (t); IR (neat) 3088, 3063, 3029, 2926, 2858, 1496, 1454, 1361, 1208, 1093, 1073, 1028, 736, 697 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~27~DO~3~SNa 444.1720, found 444.1716; \[α\]~D~^20^ (*c* 1, DCM) +2.1.

#### 1-Deutero-2,3,5-tri-*O*-benzyl-4-thio-[d]{.smallcaps}-xylitol (**28**) {#sec4.1.1.28}

![](jo-2018-025365_0036){#gr33}

Donor **4** (0.09 mmol, 0.043 g), dried by coevaporating with dry toluene (3×), was dissolved in dry DCM (3.0 mL) and stirred with freshly activated 3 Å molecular sieves at room temperature for 1 h under argon to remove traces of water. The solution was then cooled to −78 °C, and TES-*d* (0.18 mmol), dissolved in DCM (0.36 mL), was added followed by the addition of TMSOTf (0.12 mmol), dissolved in DCM (0.24 mL). Next, the reaction mixture was stirred at −30 °C for 10 days and quenched by the addition of TEA (0.5 mL). The reaction mixture was filtered through a path of Celite and concentrated in vacuo. Column chromatography (pentane/EtOAc, 99:1 to 93:7) yielded the title compound (0.023 g, 0.06 mmol, 61%, α/β = 69:31): ^1^H NMR (400 MHz, CDCl~3~) δ 7.40--7.16 (m, 15H), 4.61--4.42 (m, 6H), 4.23--4.06 (m, 2H), 3.90--3.78 (m, 2H), 3.62 (q, *J* = 3.9 Hz, 1H), 3.10 (d, *J* = 4.4 Hz, 0.69H), 2.84 (d, *J* = 2.0, 0.31H); ^13^C{^1^H} NMR (101 MHz, CDCl~3~) δ 138.3, 138.2, 138.1, 128.7--127.7, 83.0, 73.4, 72.8, 71.2, 69.4, 48.1, 32.9 (t); IR 3089, 3064, 3031, 2925, 2860, 1496, 1454, 1362, 1207, 1098, 1073, 1028, 735, 697 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\] ^+^ calcd for C~26~H~27~DO~3~SNa 444.1720, found 444.1715; \[α\]~D~^20^ (*c* 0.5, DCM) +21.1.
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